Silent Cerebral Infarct

2

Review clinical trials related to Silent Cerebral Infarct. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions

The CBI registry is a prospective, interdisciplinary, multimodal observational registry of patients with covert brain infarction. Methods: A standardized workup in analogy to manifest ischemic stroke including cerebral MRI, long-term rhythm monitoring (3 x 7 days ECG), echocardiography, laboratory work-up and risk factor assessment as well as noninvasive angiography of the cervical and intracranial arteries will be performed.

Participants needed: 230
Trial details
Age: 16+Biological sex: AllType: ObservationalSponsor: Insel Gruppe AG, University Hospital BernUpdated: Nov 14, 2024Locations: 2
Eligibility criteria

DWI positive lesions: Focus of restricted diffusion (high DWI signal and low ADC... [+3]

Projected life expectancy of less than 2 years, [+8]

Status: Recruiting

Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions

Arterial Fibrillation (AF) is well-recognized as a cause for cryptogenic Acute Ischemic Stroke (AIS) and is associated with Silent Brain Infarction (SBI). However, the role of AF in the formation of lesions (SBIs) is less well established than its role in AIS and needs clarification. The investigators hypothesize that continuous rhythm monitoring will yield a similar incidence of AF diagnosis in patients with SBI as compared to patients with cryptogenic AIS. The primary objective is to assess the cumulative incidence of AF diagnosis at 24 months in patients with SBI.

Participants needed: 150
Trial details
Age: 50+Biological sex: AllType: ObservationalSponsor: Insel Gruppe AG, University Hospital BernUpdated: Nov 14, 2024Locations: 8
Eligibility criteria

Age [+11]

History of AF or atrial flutter [+12]